rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Mannatech, Incorporated

MTEX · Nasdaq

Health CarePharmaceuticalsIn trend

MTEX stood above a rising 150-day average in 7 of the last 52 weekly readings, including each of the last 4 weeks. It is 21.0% above that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
In trend
Weeks in an uptrend
4 in a row
Industry in uptrend
31% -7 in 4 wk
Insider buys, 12 months
$124K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
15 (-1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 7 of 52 weeks.

17 Apr – 16 Oct
26%36%46%Apr 26Jun 26Jul 26Sep 26Oct 26

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$120KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months3
Sale orders, 12 months0
Buyers · sellers2 · 0
WhoDidSharesTraded
Larry A. JobeDirectorbought2,803at $4.1220 May 2026filed 21 May 2026
Kevin Andrew RobbinsDirectorbought7,100at $4.1719 May 2026filed 20 May 2026
Larry A. JobeDirectorbought5,000at $4.2019 May 2026filed 20 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders15-1 on the quarter
New · exited2 · 4
Reported value$767K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.unchanged · filed 7 Aug 202652,163$272K00.0%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 202641,528$216K-8,089−16.3%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 202630,078$157K-800−2.6%
IFG Advisory, LLCnew · filed 14 Aug 202619,090$99K+19,090
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 20262,679$14K00.0%
Tower Research Capital LLC (TRC)added · filed 11 Aug 2026727$3,788+255+54.0%
Vanguard Global Advisers, LLCunchanged · filed 13 Aug 2026250$1,30300.0%
WELLS FARGO & COMPANYadded · filed 14 Aug 2026201$1,046+200+20000.0%
UBS Group AGreduced · filed 13 Aug 202648$250-437−90.1%
NATIONAL BANK OF CANADAunchanged · filed 10 Aug 202630$15000.0%
31 Mar 2023 – 30 Jun 2026
131619Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Robert Toth Company insiderDirector · last 3 Jun 202614 · 0
Seifrick A. John Company insiderDirector · last 3 Jun 20260 · 0
Yasir Haider Company insiderChief Financial Officer · last 3 Jun 20260 · 0
Larry A. Jobe Company insiderDirector · last 20 May 202619 · 6
Kevin Andrew Robbins Company insiderDirector · last 19 May 20263 · 9
J. Stanley Fredrick Company insiderDirector · last 2 Jan 202611 · 0
Tyler Rameson Company insiderDirector · last 2 Jan 20261 · 0
Erin Kemmler Barta Company insiderGeneral Counsel · last 3 Jun 20250 · 0
James Clavijo Company insiderChief Financial Officer · last 3 Jun 20250 · 0
Landen Granvel Fredrick Company insiderPresident and CEO · last 3 Jun 20250 · 0
Alfredo Bala Company insiderCEO and President · last 30 Aug 20230 · 11
Eric W. Schrier Company insiderDirector · last 3 Jan 20221 · 0

Same industry

ABBV AbbVieLeading+20%
VTRS ViatrisLeading+16%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Dividend growthFY 2018 · to 14 Nov 2108300%

Analyst forecasts

No analyst forecasts yet.